Archive Category: Green Zone Fortunes Updates

I originally recommended buying shares of Twist Bioscience Corp. (Nasdaq: TWST) in the May issue of Green Zone Fortunes because I thought its focus on syntheticDNA gave it a uniquely advantageous position in the broader genomics industry, which I’ve said before is “the future of everything” in the health care sector.

If you’re like most investors, you think the key to beating the market is making bigger profits in “up” markets. Many of them spend a majority of their time trying to identify stocks that will go up two, three or four times faster than a benchmark, such as the S&P 500, during bull markets.

In The Bull & the Bear, Matt, Charles and I take a close look at stocks, sectors and other market news.

When I launched my six-factor Green Zone Ratings system back in April, I told you my plan was to pinpoint the best companies in the market (our Green Zone stocks.)

I reached out a couple of days early because, as we were wrapping up the monthly issue, I saw that the stock was making a bullish breakout from a consolidation pattern I’d been watching closely.